Filing Details

Accession Number:
0001393905-19-000038
Form Type:
13D Filing
Publication Date:
2019-02-05 14:25:52
Filed By:
Jeffs Richard
Company:
Cell Medx Corp. (OTCBB:CMXC)
Filing Date:
2019-02-05
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Richard Norman Jeffs 11,999,086 11,999,086 11,999,086 22.3%
Filing


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


SCHEDULE 13D/A

(Amendment No. 1)


Under the Securities Exchange Act of 1934



Cell MedX Corp.

 


COMMON STOCK, $0.001 PER SHARE PAR VALUE

(Title of Class of Securities)


15115X 107

(CUSIP Number)


RICHARD NORMAN JEFFS

11750 Fairtide Road

Ladysmith, BC, V9G 1K5 Tel: 250 619 0142

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

 

December 27, 2018

(Date of Event which Requires Filing of this Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box  [  ].




















SCHEDULE 13D/A



1

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Richard Norman Jeffs

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  [   ]

(b)  [   ]   Not Applicable

3

SEC USE ONLY

 

4

SOURCE OF FUNDS (See Instructions)

PF

5

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

                                                                  [   ]   N/A

6

CITIZENSHIP OR PLACE OF ORGANIZATION

Canada

NUMBER OF


SHARES


BENEFICIALLY


OWNED BY


EACH


REPORTING


PERSON


WITH

7

SOLE VOTING POWER

11,999,086 Shares

8

SHARED VOTING POWER

Not Applicable

9

SOLE DISPOSITIVE POWER

11,999,086 Shares

10

SHARED DISPOSITIVE POWER

Not Applicable

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

11,999,086 Shares

12

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

   [   ]   Not Applicable

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

22.3%

14

TYPE OF REPORTING PERSON (See Instructions)

IN (Individual)







Page 2 of 7




ITEM 1.

SECURITY AND ISSUER


The class of equity securities to which this Schedule 13D Statement relates is shares of common stock, par value $0.001 per share (the Shares), of Cell MedX Corp., a Nevada corporation (the Issuer). The principal executive offices of the Issuer are located at 123 W. NYE LN, SUITE 446, CARSON CITY NV 89706.



ITEM 2.

IDENTITY AND BACKGROUND


(a)

This Statement is being filed by Richard Norman Jeffs (the Reporting Person).


(b)

The Reporting Persons address is 11750 Fairtide Road, Ladysmith, BC, V9G 1K5.


(c)

The Reporting Person is a retired self-employed businessman.


(d)

During the last five years, the Reporting Person has not been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors).


(e)

During the last five years, the Reporting Person has not been a party to any civil proceeding of a judicial or administrative body of competent jurisdiction where, as a result of such proceeding, there was or is a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.


(f)

The Reporting Person is a citizen of Canada.



ITEM 3.

SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATIONS


The securities listed as beneficially owned by the Reporting Person are held directly by the Reporting Person. All securities directly held by the Reporting Person were acquired in open market or private transactions using the Reporting Persons own funds, or as partial consideration for loans made by the Reporting Person to the Issuer as described in Item 4 below.



ITEM 4.

PURPOSE OF TRANSACTION


The Reporting Persons acquisition of beneficial ownership over the Issuers securities was made for investment purposes.


The Reporting Person owns 2,000,000 warrants expiring on March 3, 2021 (the 2016 Loan Warrants) issued as partial consideration for a loan of US$50,000 made by the Reporting Person to the Issuer in March 2016. The 2016 Loan Warrants are exercisable at a price of $0.15 per share if exercised during the first year, $0.25 per share if exercised during the second year, $0.40 per share if exercised during the third year, $0.60 per share if exercised during the fourth year and $0.75 per share if exercised during the fifth year.


The Reporting Person owns an additional 5,000,000 warrants exercisable at a price of US$0.05 per share, expiring on December 27, 2021 (the Credit Line Warrants) issued as partial consideration for an unsecured line of credit advanced by the Reporting Person to the Issuer for up to US$250,000 (the Credit Line). The Credit Line Warrants vested at a rate of 20 warrants for every US$1 advanced under the Credit Line, with 2,000,000 Credit Line Warrants vesting upon issuance, and an additional 3,000,000 Credit Line Warrants vesting on January 25, 2019.



Page 3 of 7





The Reporting Person owns an additional 2,482,960 warrants exercisable at a price US$0.05 per share, expiring on December 27, 2021 (the 2018 Loan Warrants) that were issued as additional consideration for various unsecured loans advanced by the Reporting Person to the Issuer between June 2016 and August 2018 totaling US$124,128. The 2018 Loan Warrants vested at the time of issuance.


In addition to acquiring Shares upon the exercise of the 2016 Loan Warrants, the Credit Line Warrants and the 2018 Loan Warrants, the Reporting Person may, from time to time, acquire additional securities of the Issuer and retain or sell all or a portion of the Issuers securities held by the Reporting Person in open market transactions or in privately negotiated transactions.


Other than as disclosed above, as of the date hereof, the Reporting Person does not have any plans or proposals which relate to or would result in:


(a)

the acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer;


(b)

an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries;


(c)

a sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries;


(d)

any change in the present board of directors or management of the Issuer including any plans or proposals to change the number of term of directors or to fill any existing vacancies on the board;


(e)

any material change in the present capitalization or dividend policy of the Issuer;


(f)

any other material change in the Issuers business or corporate structure;


(g)

changes in the Issuers Articles of Incorporation or other actions which may impede the acquisition of control of the Issuer by any person;


(h)

causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association;


(i)

a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Exchange Act; or


(j)

any action similar to any of those enumerated above.



ITEM 5.

INTEREST IN SECURITIES OF THE ISSUER


(a)

Aggregate Beneficial Ownership:


As of February 5, 2019, the Reporting Person beneficially owned the following securities of the Issuer:


Name

Title of Security

Amount

Percentage of Shares of

Common Stock(1)

Richard Norman Jeffs

Common Stock

11,999,086 Shares(2)

(direct)

22.3%





Page 4 of 7





Under Rule 13d-3, a beneficial owner of a security includes any person who, directly or indirectly, through any contract, arrangement, understanding, relationship, or otherwise has or shares: (i) voting power, which includes the power to vote, or to direct the voting of Shares; and (ii) investment power, which includes the power to dispose or direct the disposition of Shares. Certain shares may be deemed to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of the Shares). In addition, Shares are deemed to be beneficially owned by a person if the person has the right to acquire the Shares (for example, upon exercise of an option) within 60 days of the date as of which the information is provided. In computing the percentage ownership of any person, the amount of Shares outstanding is deemed to include the amount of shares beneficially owned by such person (and only such person) by reason of these acquisition rights. As a result, the percentage of outstanding shares of any person as shown in this table does not necessarily reflect the persons actual ownership or voting power with respect to the number of Shares actually outstanding on the date of this Statement.


(1)

Applicable percentage of ownership is based on 44,282,749 Shares outstanding as of February 5, 2019 plus any securities held by such security holder exercisable for or convertible into common shares within sixty (60) days after the date of this Report, in accordance with Rule 13d-3(d)(1) under the Securities Exchange Act of 1934, as amended.


(2)

Includes 2,516,126 shares of the Issuers common stock, plus 2,000,000 shares acquirable on exercise of share purchase warrants exercisable for a period of five years at a price of $0.15 per share if exercised during the first year, $0.25 per share if exercised during the second year, $0.40 per share if exercised during the third year, $0.60 per share if exercised during the fourth year and $0.75 per share during the fifth year, and 7,482,960 shares acquirable on exercise of share purchase warrants exercisable for a period of three years at a price of $0.05 per share.


(b)

Power to Vote and Dispose of the Issuer Shares:


Sole Power


The Reporting Person has the sole power to vote or to direct the vote of the Shares held in his name and has the sole power to dispose of or to direct the disposition of the Shares held in his name.


Shared Power


None.


(c)

Transactions Effected During the Past 60 Days:


Except for those transactions described in this Information Statement and as below, the Reporting Person has not effected any transactions in the Issuers securities during the 60 days prior to the date hereof:


Date of Transaction

Transaction

December 27, 2018

Acquisition of 7,482,960 share purchase warrants pursuant to Credit Line Agreement


(d)

Right of Others to Receive Dividends or Proceeds of Sale:


Not Applicable.


(e)

Date Ceased to be the Beneficial Owner of More Than Five Percent:


Not Applicable.




Page 5 of 7





ITEM 6.

CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER


Not applicable.



ITEM 7.

MATERIAL TO BE FILED AS EXHIBITS


Not applicable.




















Page 6 of 7





SIGNATURE


After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


 

February 5, 2019

 

 

 

/s/ Richard Norman Jeffs

 

Richard Norman Jeffs











































Page 7 of 7